← FDA Drug Approvals (Drugs@FDA)
CARDAMYST
NDA · New Drug Application · Sponsor: MILESTONE PHARMS USA · Approved 2025-12-12
Drug application
- FDA Application #
NDA218571- Application type
- New Drug Application
- Brand name
- CARDAMYST
- Generic name
- ETRIPAMIL
- Active ingredients
- ETRIPAMIL
- Dosage form
- SPRAY
- Route
- NASAL
- Marketing status
- Prescription
- Sponsor
- MILESTONE PHARMS USA
- Manufacturer
- Milestone Pharmaceuticals USA, Inc.
- First approval
- 2025-12-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown